Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide.
Actas Urol Esp (Engl Ed)
; 46(5): 301-309, 2022 06.
Article
in En, Es
| MEDLINE
| ID: mdl-35256324
Key words
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Trofoterapia
Main subject:
Prostatic Neoplasms, Castration-Resistant
/
Abiraterone Acetate
Type of study:
Prognostic_studies
Language:
En
/
Es
Journal:
Actas Urol Esp (Engl Ed)
Year:
2022
Type:
Article